Skip to main content

Table 2 Symptoms and blood laboratory data in patients with VL, stratified according to risk group

From: Varied spectrum of clinical presentation and mortality in a prospective registry of visceral leishmaniasis in a low endemicity area of Northern Italy

 

Children (19pts)

ICC (17pts)

ISS HIV+ (10pts)

ISS HIV-(9pts)

Constitutional Symptoms

19(100%)

15 (88.2%)

10 (100%)

9 (100%)

Hepato + Splenomegaly

19 (100)

11 (65%)

8 (8%)

6 (66%)

Lymphoadenopathy

0

1 (6%)

0

0

Other symptoms

0

0

2 (20%)

1 (1%)

Haematological data

18 (95%)

17(100%)

10(100%)

9(100%)

--Anemia

12(63.2%)

10(58.8%)

10(100%)

6(66.6%)

--Leukopenia

15(78.9%)

8(47.1%)

8(80%)

0

--Trombocytopenia

 

2(11.8%)

1(10%)

0

--Pancytopenia

 

0

6(60%)

2(33.3%)

-Hypergammaglobulinemia

15((78.9%)

5(29.4%)

8(80%)

6(66.6%)